Find NINDS Clinical Trials

Find NINDS Clinical Trials

Subscribe to Find NINDS Clinical TrialsRSS
Filter By:
Returning 78 results
Study Title Location Statussort descending Disorders
A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients Maryland Completed Multiple Sclerosis
Minocycline to Treat Amyotrophic Lateral Sclerosis International Locations Completed Amyotrophic Lateral Sclerosis
Assessment of Patients With Multiple Sclerosis (MS) Maryland* Completed Herpesviridae Infection, HTLV-I Infection, Multiple Sclerosis, Tropical Spastic Paraparesis, Vasculitis
A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia Maryland* Completed Chronic Dysphagia, Multiple Sclerosis, Parkinson Disease
Clinical Trial of High Dose CoQ10 in ALS Multiple U.S. Locations Completed Amyotrophic Lateral Sclerosis, Lou Gehrig's Disease
Compassionate Use of Ceftriaxone in Patients With Amyotrophic Lateral Sclerosis (ALS) No documented Location Completed Amyotrophic Lateral Sclerosis, Cerebrospinal Fluid, Neurodegenerative Disease, Motor Neuron Disease
Clinical Trial Ceftriaxone in Subjects With ALS Multiple U.S. Locations Completed Amyotrophic Lateral Sclerosis, ALS
A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) Multiple U.S. Locations Completed Relapsing Remitting Multiple Sclerosis
Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS) Multiple U.S. Locations Completed Amyotrophic Lateral Sclerosis, Lou Gehrig's Disease, Primary Lateral Sclerosis, Nervous System Diseases, Hereditary Spastic Paraparesis
Zenapax to Treat Multiple Sclerosis Maryland* Completed Multiple Sclerosis

Pages